CN1731981B - 糖皮质激素的脂质体 - Google Patents

糖皮质激素的脂质体 Download PDF

Info

Publication number
CN1731981B
CN1731981B CN2003801074820A CN200380107482A CN1731981B CN 1731981 B CN1731981 B CN 1731981B CN 2003801074820 A CN2003801074820 A CN 2003801074820A CN 200380107482 A CN200380107482 A CN 200380107482A CN 1731981 B CN1731981 B CN 1731981B
Authority
CN
China
Prior art keywords
liposome
lipid
mol
liposomes
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2003801074820A
Other languages
English (en)
Chinese (zh)
Other versions
CN1731981A (zh
Inventor
斯特芬·潘茨纳
罗尔夫·布罗伊尔
雷蒙德·W.·金内
乌纳·劳赫豪斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novosom AG
Original Assignee
Novosom AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novosom AG filed Critical Novosom AG
Publication of CN1731981A publication Critical patent/CN1731981A/zh
Application granted granted Critical
Publication of CN1731981B publication Critical patent/CN1731981B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2003801074820A 2002-11-24 2003-11-24 糖皮质激素的脂质体 Expired - Fee Related CN1731981B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10255106.5 2002-11-24
DE10255106A DE10255106A1 (de) 2002-11-24 2002-11-24 Liposomale Glucocorticoide
PCT/DE2003/003893 WO2004047792A2 (de) 2002-11-24 2003-11-24 Liposomale glucocorticoide

Publications (2)

Publication Number Publication Date
CN1731981A CN1731981A (zh) 2006-02-08
CN1731981B true CN1731981B (zh) 2010-06-16

Family

ID=32308712

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2003801074820A Expired - Fee Related CN1731981B (zh) 2002-11-24 2003-11-24 糖皮质激素的脂质体

Country Status (9)

Country Link
US (1) US20060147511A1 (https=)
EP (1) EP1581185B1 (https=)
JP (1) JP2006509750A (https=)
CN (1) CN1731981B (https=)
AT (1) ATE445389T1 (https=)
AU (1) AU2003294635B8 (https=)
CA (1) CA2507316A1 (https=)
DE (2) DE10255106A1 (https=)
WO (1) WO2004047792A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004257375A1 (en) * 2003-07-21 2005-01-27 Vasogen Ireland Limited Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
EP1793805A1 (en) * 2004-09-09 2007-06-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions
US7744920B2 (en) * 2004-09-09 2010-06-29 Hadasit Medical Research Services & Development Limited Use of liposomal glucocorticoids for treating inflammatory states
AU2006256351B2 (en) 2005-06-10 2011-08-04 Pola Chemical Industries Inc. Novel triterpenic acid derivative and preparation for external application for skin comprising the same
JP4980634B2 (ja) * 2006-03-17 2012-07-18 ポーラ化成工業株式会社 肌荒れの予防、改善に好適な皮膚外用剤
US20080027371A1 (en) * 2006-07-26 2008-01-31 Higuchi John W Method and device for minimally invasive site specific ocular drug delivery
ES2599630T3 (es) * 2006-09-28 2017-02-02 Hadasit Medical Research Services & Development Limited Uso de glicerofosfolípidos para lubricación de las articulaciones
JP5424885B2 (ja) * 2006-10-13 2014-02-26 マリーナ バイオテック，インコーポレイテッド 両性リポソームにおけるまたは両性リポソームに関する改善、両性リポソームを処方する方法および両性リポソームに充填する方法
CA2702103A1 (en) * 2007-10-12 2009-04-16 Novosom Ag Improvements in or relating to amphotaric liposomes comprising neutral lipids
EP2127639A1 (en) * 2008-05-26 2009-12-02 Universiteit Utrecht Holding B.V. Corticosteroid containing liposomes for treatment of cardiovascular diseases
EP2415464B1 (en) * 2009-03-30 2017-05-10 Eisai R&D Management Co., Ltd. Method for producing liposome composition
ES2593027T3 (es) 2009-03-30 2016-12-05 Eisai R&D Management Co., Ltd. Composición liposomal
CN102366411B (zh) * 2011-09-14 2012-12-19 海南灵康制药有限公司 一种地塞米松棕榈酸酯脂质体注射液
PT2773325T (pt) * 2011-11-04 2018-12-19 Enceladus Pharmaceuticals B V Corticosteróides lipossômicos para o tratamento de transtornos inflamatórios em humanos
EP3095440B1 (en) 2015-05-19 2020-01-15 PLS-Design GmbH Antigen-specific immunotherapy using tolerizing liposomes
CN106177959A (zh) * 2016-04-01 2016-12-07 北京大学 抗癌组合物及其制剂和应用
US12029724B2 (en) 2016-04-28 2024-07-09 Eisai R&D Management Co., Ltd. Method for inhibiting tumor growth
JP2019515925A (ja) * 2016-04-29 2019-06-13 エンセラドゥス ファーマセウティカルス べー．フェー． 炎症性病変又は領域に局所注射するためのリポソーム化コルチコステロイド
CN111065423B (zh) * 2017-08-22 2022-04-12 莫比斯医疗有限公司 用于关节润滑的脂质体制剂
EP3787670A1 (en) 2017-10-18 2021-03-10 Luxembourg Institute of Health (LIH) Induction of allergen-specific tregs prior to oral or sublingual immunotherapy of food allergy
WO2019076478A1 (en) 2017-10-18 2019-04-25 Luxembourg Institute Of Health (Lih) OLIGODESOXYNUCLEOTIDES INCORPORATED IN HYDROGEL AS TOLEROGENEOUS ADJUVANT FOR SUB-CUTANEOUS IMMUNOTHERAPY
US12083138B2 (en) * 2018-07-09 2024-09-10 Taiwan Liposome Co., Ltd. Methods to reduce complications of intra-articular steroid
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
US12036204B2 (en) 2019-07-26 2024-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN110974954B (zh) * 2019-12-24 2021-03-16 珠海丽凡达生物技术有限公司 一种用于增强核酸疫苗免疫效果的脂质纳米颗粒及其制备方法
CN111494320A (zh) * 2020-04-24 2020-08-07 上海交通大学医学院附属仁济医院 一种载糖皮质激素的纳米载体及其制备和应用
EP4522178A1 (en) 2023-01-19 2025-03-19 Moebius Medical Ltd. A long-acting liposomal composition for treatment of pain in articular disorders
CN117357480B (zh) * 2023-12-08 2024-03-29 北京中科利华医药研究院有限公司 无针经皮注射用组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
JPS59222410A (ja) * 1983-06-01 1984-12-14 Terumo Corp 薬物保持リポソ−ム製剤
JPS61197513A (ja) * 1985-02-25 1986-09-01 Ichimaru Fuarukosu Kk 主薬物を内包した安定なリポソ−ムの製剤化法
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6120800A (en) * 1997-09-25 2000-09-19 Nexstar Pharmaceuticals, Inc. Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
EP1073425A1 (en) * 1998-04-30 2001-02-07 The University Of Cincinnati Fibrinogen coated droplets of liquid hydrophobic phases
EP1046394A3 (en) * 1999-04-19 2001-10-10 ImaRx Pharmaceutical Corp. Novel compositions useful for delivering compounds into a cell
ES2327025T3 (es) * 1999-06-25 2009-10-23 Terumo Kabushiki Kaisha Liposomas.
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
NZ527832A (en) * 2001-03-13 2006-03-31 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms
EP1371362A1 (en) * 2002-06-12 2003-12-17 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Sandra Suarez et al..Effect of dose and release rate on pulmonary targeting ofliposomal triamcinolone acetonide phosphate.PHARMACEUTICAL RESEARCH15 3.1998,摘要，第461页右栏倒数第1段-第462页第1段.
Sandra Suarez et al..Effect of dose and release rate on pulmonary targeting ofliposomal triamcinolone acetonide phosphate.PHARMACEUTICAL RESEARCH15 3.1998,摘要,第461页右栏倒数第1段-第462页第1段. *
李安良 等主编.《药物化学》.高等教育出版社,1999,第429页.
李安良等主编.《药物化学》.高等教育出版社,1999,第429页. *
毕殿洲 主编.《药剂学》.人民卫生出版社,2001,第453-454页. *

Also Published As

Publication number Publication date
DE50312034D1 (de) 2009-11-26
CN1731981A (zh) 2006-02-08
EP1581185A2 (de) 2005-10-05
AU2003294635A2 (en) 2004-06-18
US20060147511A1 (en) 2006-07-06
CA2507316A1 (en) 2004-06-10
DE10255106A1 (de) 2004-06-09
JP2006509750A (ja) 2006-03-23
WO2004047792A2 (de) 2004-06-10
WO2004047792A3 (de) 2004-08-12
EP1581185B1 (de) 2009-10-14
ATE445389T1 (de) 2009-10-15
AU2003294635B2 (en) 2009-05-28
AU2003294635A1 (en) 2004-06-18
AU2003294635B8 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
CN1731981B (zh) 糖皮质激素的脂质体
CN114191561B (zh) 一种可离子化脂质化合物在核酸药物递送系统中的应用
US5043165A (en) Novel liposome composition for sustained release of steroidal drugs
CN105148278B (zh) 包含磷脂和胆固醇的眼部药物递送系统
EP2919760B1 (en) Liposomes with an anchored blood brain barrier recognition peptide for an improved delivery of a drug into the brain
CN101043875B (zh) 糖皮质激素和糖皮质激素衍生物的脂质体组合物
CN111372580A (zh) 包含弱酸药物的脂质体组合物及其用途
CN107260679B (zh) 用以减少眼用类固醇的并发症的药物组合物
JPH11512712A (ja) 生物学的に活性な物質を細胞に送達するためのエマルジョンおよびミセル処方物
CA2115364A1 (en) Composition and method for treating cystic fibrosis
CN1531424A (zh) Sn-38类脂络合物和应用的方法
JP2004517835A (ja) 炎症性疾患の治療用組成物
JPH07505408A (ja) 治療及び診断用組成物及びその製造方法，ならびにその用途
US6562371B1 (en) Liposomes
JPWO1991007973A1 (ja) 脂肪乳剤
JP2001055343A (ja) リポソーム
KR102902665B1 (ko) 에틸렌글리콜을 포함한 생분해성 이온화 지질 및 이를 이용한 약물 전달용 지질나노입자
RU2730488C1 (ru) Фармацевтическая композиция на основе глюкокортикостероида будесонида и фосфатидилхолина для сухой ингаляции
TW202415382A (zh) 脂質體藥物組合物及其製備方法和用途
CN121927063A (zh) 用于减少adc药物诱发炎症相关不良反应的制剂及其制备方法和应用
HK40130005A (zh) 脂质纳米颗粒制剂
CN118512414A (zh) 一种具有器官靶向能力的低免疫原性脂质纳米粒及其制备方法与应用
JPWO1991007962A1 (ja) 脂肪乳剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100616

Termination date: 20101124